Mainz Biomed Earnings Estimates, EPS & Revenue | NASDAQ:MYNZ

Comments

Mainz Biomed NV Earnings Estimates

MYNZNASDAQ

Trade with Public

$0.8300

0.01862.29%

At close: Mar 6, 4:00 PM EST

$0.8700

0.044.82%

After Hours: 7:57 PM EST

Overview NewsEarningsAnalyst Ratings Insider Trades Short Interest Stock Report

Mainz Biomed Earnings Estimates, EPS & Revenue | NASDAQ:MYNZ

Mainz Biomed (MYNZ) is scheduled to report FY earnings on April 15, 2026. Analysts estimate EPS of $-2.52 and quarterly revenue of $957.00K.

In the most recent quarter (H1), Mainz Biomed reported EPS of $-2.65, missing estimates of $-2.00 by 0.33%. Revenue came in at $286.72K, exceeding the estimate of $0.00 by 0.00%.

Mainz Biomed has missed EPS estimates in 3 consecutive quarters.

Over the last 4 quarters, Mainz Biomed has averaged an EPS surprise of 2.20% and a revenue surprise of 0.97%.

Earnings Date

Apr 15

EPS Estimate

$-2.520

Quarterly Revenue Estimate

$957.00K

Annual Revenue
(as of Jun 30)

$659.93K

Mainz Biomed Earnings History

Analyze the earnings history of Mainz Biomed using advanced sorting and filters.

Mainz Biomed (MYNZ) Earnings Per Share

The chart below shows Mainz Biomed's reported EPS compared to analyst estimates over recent quarters.

Mainz Biomed (MYNZ) Revenue

The chart below shows Mainz Biomed's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Mainz Biomed (NASDAQ:MYNZ) reporting earnings?

Mainz Biomed (MYNZ) is scheduled to report earnings on April 15, 2026. The last reported earnings were for reported on September 26, 2025 for H1.

What were the latest earnings per share (EPS) for Mainz Biomed (NASDAQ:MYNZ)?

The Actual EPS was $-2.65, which missed the estimate of $-2.00.

What were Mainz Biomed’s (NASDAQ:MYNZ) revenues?

The Actual Revenue was $286.72K, which beat the estimate of $0.00.

People Also Watch

Ernexa Therapeutics Inc

Can Fite Biopharma Ltd

Bolt Biotherapeutics Inc

NASDAQ:BOLT

$4.39

2.02%

AIxCrypto Holdings Inc

NASDAQ:AIXC

$1.08

-1.82%

CollPlant Biotechnologies Ltd

NASDAQ:CLGN

$0.68

12.44%

Mainz Biomed Earnings Estimates, EPS & Revenue | NASDAQ:MYNZ

Mainz Biomed (MYNZ) is scheduled to report FY earnings on April 15, 2026. Analysts estimate EPS of $-2.52 and quarterly revenue of $957.00K.

In the most recent quarter (H1), Mainz Biomed reported EPS of $-2.65, missing estimates of $-2.00 by 0.33%. Revenue came in at $286.72K, exceeding the estimate of $0.00 by 0.00%.

Mainz Biomed has missed EPS estimates in 3 consecutive quarters.

Over the last 4 quarters, Mainz Biomed has averaged an EPS surprise of 2.20% and a revenue surprise of 0.97%.

Earnings Date

Apr 15

EPS Estimate

$-2.520

Quarterly Revenue Estimate

$957.00K

Annual Revenue
(as of Jun 30)

$659.93K